Abstract
In stroke patients, multitracer positron emission tomography (PET) permits the assessment of acute changes in regional cerebral blood flow (rCBF), blood volume (rCBV), oxygen consumption (rCMRO2) and glucose metabolism (rCMRgl), which are the initial steps in the complex molecular and biochemical process leading to ischaemic cell damage. While early infarcts exhibit low flow and oxygen consumption, increased oxygen extraction fraction (OEF) due to preserved metabolism at reduced flow suggests viability of tissue. However, most initially “viable” tissue will be metabolically deranged and will become necrotic in the further course; only in a few instances do these tissue compartments recover to normal function. Increased glucose uptake at reduced oxygen supply induces non-oxidative glycolysis with noxious lactacidosis, whereas hyperperfusion beyond the metabolic demand is of controversial effect. In subacute or chronic states after ischaemia reduced flow can be compensated by increased blood volume; when perfusional reserve is exhausted, oxygen extraction increases. Such findings may guide therapeutic decisions and predict the severity of permanent deficits. Functional deactivation of tissue remote from the lesion is found regularly as a sign of damaged connecting pathways. Flow and metabolic studies during the performance of specific tasks help to detect alternative functional loops and may yield prognostic information. Repeat studies in the course of stroke are employed for the evaluation of therapeutic strategies targeted to improve reperfusion or to effect metabolic or biochemical alterations. In the future PET may gain additional clinical importance when patients are selected for elective treatment according to the prevailing pathophysiological pattern.
Similar content being viewed by others
References
Heiss W-D. Experimental evidence for ischemic thresholds and functional recovery. Stroke 1992;23:1668–1672.
Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc Brain Metab Rev 1991;3:213–245.
Choi DW. Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 1990;2:105–147.
Ginsberg MD. Local metabolic responses to cerebral ischemia. Cerebrovasc Brain Metab Rev 1990;2:58–93.
Siesjö BK, Katsura K, Pahlmark K, Smith ML. The multiple causes of ischemic brain damage: a speculative synthesis. In: Krieglstein J, Oberpichler-Schwenk H, eds. Pharmacology of cerebral ischemia 1992. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1992:511–525.
Baron JC, Rougemont D, Bousser MG, Lebrun-Grandié P, Iba-Zizen MT, Chiras J. Local CBF, oxygen extraction fraction (OEF), and CMRO2: prognostic value in recent supratentorial infarction in humans. J Cereb Blood Flow Metab 1983;3 Suppl 1:S1-S2.
Powers WJ, Grubb RL Jr, Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab 1985;5:600–608.
Baron JC. Ischemic stroke studied by 150-labeled compounds: misery perfusion and luxury perfusion. In: Heiss W-D, Pawlik G, Herholz K, Wienhard K, eds. Clinical efficacy of positron emission tomography. Dordrecht: Martinus Nijhoff; 1987:15–23.
Powers WJ, Grubb RL Jr, Raichle ME. Physiological responses to focal cerebral ischemia in humans. Ann Neurol 1984;16:546–552.
Baron JC, Bousser MG, Comar D, Soussaline F, Castaigne P. Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo: potentials, limitations and clinical applications in cerebral ischemic disorders. Eur Neurol 1981;20:273–284.
Kuhl DE, Phelps ME, Kowell AP, Metter EJ, Selin C, Winter J. Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3. Ann Neurol 1980;8:47–60.
Hakim AM, Evans AC, Berger L, et al. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab 1989;9:523–534.
Wise RJS, Bernardi S, Frackowiak RSJ, Legg NJ, Jones T. Serial observations on the pathophysiology of acute stroke. Brain 1983;106:197–222.
Wise RJS, Rhodes CG, Gibbs JM, Hatazawa J, Palmer T, Frackowiak RSJ, Jones T. Disturbance of oxidative metabolism of glucose in recent human cerebral infarcts. Ann Neurol 1983;14:627–637.
Berkelbach van der Sprenkel JWB, Luyten PR, Vanrijen PC, Tulleken CAF, Den Hollander JA. Cerebral lactate detected by regional proton magnetic-resonance spectroscopy in a patient with cerebral infarction. Stroke 1988;19:1556.
Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Cerebral metabolism in man after acute stroke —new observations using localized proton NMR spectroscopy. Magn Reson Med 1989;9:126–131.
Heiss W-D, Huber M, Fink G, Herholz K, Pietrzyk U, Wagner R, Wienhard K. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992;12:193–203.
Baron JC, Frackowiak RSJ, Herholz K, Jones T, Lammertsma AA, Mazoyer B, Wienhard K. Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease. J Cereb Blood Flow Metab 1989;9:723–742.
Pietrzyk U, Herholz K, Heiss W-D. Three-dimensional alignment of functional and morphological tomograms. J Comput Assist Tomogr 1990;14:51–59.
Lassen NA. The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain. Lancet 1966;II:1113–1115.
Ackerman RH, Correia JA, Alpert NM, Haley EC Jr, Buxton RB, Elmaleh DR, Taveras JM. PET studies of stroke. In: Reivich M, Alavi A, eds. Positron Emission tomography. New York: Liss;1985:249–262.
Herholz K, Heiss W-D. Use of PET to evaluate acute stroke and other cerebrovascular disorders. In: Diksic M, Reba RC, eds. Radiopharmaceuticals and brain pathology studied with PET and SPECT Boca Raton: CRC Press; 1991:217–239.
Fink GR, Herholz K, Pietrzyk U, Huber M, Heiss W-D. Periinfarct perfusion in human ischemia: its relation to tissue metabolism, morphology, and clinical outcome. J Stroke Cerebrovasc Dis 1993;3:123–131.
Marchal G, Serrati C, Rioux P, et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome. Lancet 1993;341:925–927.
Hakim AM, Hogan MJ. In vivo binding of nimodipine in the brain. The effect of focal cerebral ischemia. J Cereb Blood Flow Metab 1991;11:762–770.
Shimada N, Graf R, Rosner G, Heiss W-D. Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid. J Neurochem 1993;60:66–71.
Welsh FA, Moyer DJ, Harris VA. Regional expression of heat shock protein-70 mRNA and c-fos mRNA following focal ischemia in rat brain. J Cereb Blood Flow Metab 1992;12:204–212.
Baron JC, Bousser MG, Comar D, Castaigne P. “Crossed cerebellar diaschisis” in human supratentorial brain infarction. Trans Am Neurol Assoc 1980;105:459–461.
Pawlik G, Herholz K, Beil C, Wagner R, Wienhard K, Heiss W-D. Remote effects of focal lesions on cerebral blood flow and metabolism. In: Heiss W-D, ed. Functional mapping of the brain in vascular disorders. Berlin Heidelberg New York: Springer;1985:59–84.
Mies G, Auer LM, Ebhardt G, Traupe H, Heiss W-D. Flow and neuronal density in tissue surrounding chronic infarction. Stroke 1983;14:22–27.
Feeney DM, Baron JC. Diaschisis. Stroke 1986;17:817–830
Metter EJ, Mazziotta JC, Itabashi HH, Mankovich NJ, Phelps ME, Kuhl DE. Comparison of glucose metabolism, x-ray CT, and post-mortem data in a patient with multiple cerebral infarcts. Neurology 1985;35:1695–1701.
Kushner M, Alavi A, Reivich M, Dann R, Burke A, Robinson G. Contralateral cerebellar hypometabolism following cerebral insult: a positron emission tomographic study. Ann Neurol 1984;15:425–434.
Martin WRW Raichle ME. Cerebellar blood flow and metabolism in cerebral hemisphere infarction. Ann Neurol 1983;14:168–176.
Baron JC, D'Antona R, Pantano P, Serdaru M, Samson Y Bousser MG. Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man. Brain 1986;109:1243–1259.
Szelies B, Herholz K, Pawlik G, Karbe H, Hebold I, Heiss WD. Widespread functional effects of discrete thalamic infarction. Arch Neurol 1991;48:178–182.
Kushner M, Reivich M, Fieschi C, Silver F, Chawluk J, Rosen M, Greenberg J, Burke A, Alavi A. Metabolic and clinical correlates of acute ischemic infarction. Neurology 1987;37:1103–1110.
Metter EJ, Kempler D, Jackson C, Hanson WR, Mazziotta JC, Phelps ME. Cerebral glucose metabolism in Wernicke's, Broca's, and conduction aphasia. Arch Neurol 1989;46:27–34.
Karbe H, Herholz K, Szelies B, Pawlik G, Wienhard K, Heiss W-D. Regional metabolic correlates of Token test results in cortical and subcortical left hemispheric infarction. Neurology 1989;39:1083–1088.
Metter EJ, Riege WH, Hanson WR, Jackson CA, Kempler D, van Lancker D. Subcortical structures in aphasia. An analysis based on (F-18) fluorodeoxyglucose, positron emission tomography, and computed tomography. Arch Neurol 1988;45:1229–1234.
von Monakow C. Die Lokalisation im Großhirn and der Abbau der Funktion durch kortikale Herde. Wiesbaden: Bergmann, 1914.
Reivich M. Crossed cerebellar diaschisis. Am J Neuroradiology 1992;13:62–64.
Fisher CM. Ataxic hemiparesis: a pathologic study. Arch Neurol 1978;35:126–138.
Gibbs JM, Wise RJS, Leenders KL, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet 1984;1:310–314.
Powers WJ, Press GW Grubb RL Jr, Gado M, Raichle ME. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann Intern Med 1987;106:27–35.
Itoh M, Hatazawa J, Pozzilli C, et al. Hemodynamics and oxygen metabolism in patients after reversible ischemic attack or minor ischemic stroke assessed with positron emission tomography. Neuroradiology 1987;29:416–421.
Chollet F, DiPiero V, Wise RJS, Brooks DJ, Dolan RJ, Frackowiak RSJ. The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol 1991;29:63–71.
Weiller C, Chollet F, Friston KJ, Wise RJS, Frackowiak RSJ. Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol 1992;31:463–472.
Heiss W-D, Kessler J, Karbe H, Fink GR, Pawlik G. Cerebral glucose metabolism as a predictor of recovery from aphasia in ischemic stroke. Arch Neurol 1993;50:958–964.
Gibbs JM, Wise RJS, Thomas DJ, Mansfield AO, Ross Russel RW Cerebral hemodynamic changes after extracranial-intracranial bypass surgery. J Neurol Neurosurg Psychiatry 1987;50:140–150.
Powers WJ, Martin WRW, Herscovitch P, Raichle ME, Grubb RL Jr. Extracranial-intracranial bypass surgery: hemodynamic and metabolic effects. Neurology 1984;34:1168–1174.
Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982;239:57–69.
Hakim AM. Hemodynamic and metabolic studies in stroke. Semin Neurol 1989;9:286–292.
Baron JC, Bousser MG, Rey A, Guillard A, Comar D, Castaigne P. Reversal of focal “misery-perfusion syndrome” by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. Stroke 1981;12:454–459.
Yamauchi H, Fukuyama H, Fujimoto N, Nabatame H, Kimura J. Significance of low perfusion with increased oxygen extraction fraction in a case of internal carotid artery stenosis. Stroke 1992;23:431–432.
Ogawa A, Kameyama M, Muraishi K, Yoshimoto T, Ito M, Sakurai Y. Cerebral blood flow and metabolism following superficial temporal artery to superior cerebellar artery bypass for vertebrobasilar occlusive disease. J Neurosurg 1992;76:955–960.
Powers WJ, Grubb RL Jr, Raichle ME. Clinical results of extracranial-intracranial bypass surgery in patients with hemodynamic cerebrovascular disease. J Neurosurg 1989;70:61–67.
EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. N Engl J Med 1985;313:1191–1200.
Gelmers HG, Gorter K, De Weerdt CJ, Wiezer HJA. A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 1988;318:203–207.
Heiss W-D, Holthoff V, Pawlik G, Neveling M. Effect of nimodipine on regional cerebral glucose metabolism in patients with acute ischemic stroke as measured by positron emission tomography. J Cereb Blood Flow Metab 1990;10:127–132.
The American Nimodipine Study Group. Clinical trial of nimodipine in acute ischemic stroke. Stroke 1992;23:3–8.
Andiné P, Rudolphi KA, Fredholm BB, Hagberg H. Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CAI of rat hippocampus during transient ischaemia. Br J Pharmacol 1990;100:814–818.
Author information
Authors and Affiliations
Additional information
Correspondence to: W.-D. Heiss
Rights and permissions
About this article
Cite this article
Heiss, WD., Herholz, K. Assessment of pathophysiology of stroke by positron emission tomography. Eur J Nucl Med 21, 455–465 (1994). https://doi.org/10.1007/BF00171424
Issue Date:
DOI: https://doi.org/10.1007/BF00171424